Cannabinoid Science

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology

DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.

HempMy Pet and Tarleton University announce positive results of their study using CBD on horses

HempMy Pet, a division of HM Health, LLC, offers CBD-infused products for dogs, cats, and horses.

Mindset Pharma develops an intranasal platform for psychedelic medicines

Mindset Pharma is focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological disorders.

A2W Pharma and MedC Biopharma Partner to develop Cannabinoid Therapeutics

A2W is a subsidiary of Amino Chemicals of Malta, which is a subsidiary of ABA Chemicals of China, a global pharmaceutical company.

InMed seeks patents for cannabinoid analogs

The patent application covers new chemical entities that can be compared to other drugs in order to select candidates for advancement.

Trait Biosciences advances water-soluble cannabinoid technology to prepare for 2022 product launch

Trait Biosciences is a leader in cannabinoid research, focused on developing technologies that enable the production of safe CBD produccts.

Vancouver-based Trait Biosciences advances its technology for the CBD infused product market

Trait is developing cannabinoid technologies delivering water-soluble extracts to formulate higher quality CBD infused products.

MD Farma closes funding and changes name to Corganics to expand cannabinoid product lines

Corganics' clinical cannabinoid therapy portfolio is available exclusively through healthcare professionals.

Medicortex FInland Oy seeks investment to develop a rapid diagnostic test to detect concussions

The investments will also pave the way towards an IPO – Medicortex has reached a point of maturity developing the prototype, and is ready...

Jazz Pharmaceuticals completes acquisition of cannabinoid medicine developer GW Pharmaceuticals

We are combining two companies that share a passion for, and track record of, developing differentiated therapies that advance science...

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth...

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader "Adds high-growth...

Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions...

Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions of the SARS-CoV-2 Spike Protein in the...

Indication Bioscience Granted First Patent for Statin Plus Cannabidiol (CBD) Combination

"...announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent US10835501B2, which relates to...